Evidence map›Paper›PMID 42265337›Full record

ArticleScientific reports2026

Integrated surveillance for lymphatic filariasis and other infectious diseases with a nationwide non-communicable disease STEPwise survey in the small Pacific Island Nation of Niue, 2025.

Adam T Craig, Harriet L S Lawford, Grizelda Mokoia, Patricia Tatui, Misiona Nicolas, Andy Manu, Amanda Murphy, Tonia Marquardt, Leanne J Robinson, Fiona Angrisano and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adam T CraigFrazer Institute, The University of Queensland, Brisbane, QLD, Australia. adam.craig@uq.edu.au.
Harriet L S LawfordFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Grizelda MokoiaDepartment of Health, Alofi, Niue.
Patricia TatuiDepartment of Health, Alofi, Niue.
Misiona NicolasDepartment of Health, Alofi, Niue.
Andy ManuDepartment of Health, Alofi, Niue.
Amanda MurphyAustralian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia.
Tonia MarquardtNational Centre for Immunisation Research and Surveillance, Sydney, NSW, Australia.
Leanne J RobinsonBurnet Institute, Melbourne, VIC, Australia.
Fiona AngrisanoBurnet Institute, Melbourne, VIC, Australia.
Colleen L LauFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.

Funding

Global Institute for Disease Elimination FADE2024/03National Centre for Immunisation Research and Surveillance 25_0270National Health and Medical Research Council 1193826National Health and Medical Research Council 2017630UQ Health Research Accelerator (HERA) Initiative (2021-2028) N/A
6 · The paper itself

Abstract

The small Pacific island nation of Niue was validated by the WHO in 2016 as having eliminated lymphatic filariasis (LF) as a public health problem; however, no post-validation surveillance (PVS) has been conducted since. In 2025, LF-PVS was integrated into a near-census national WHO STEPwise non-communicable disease (NCD) risk factor survey, a cost-effective approach for estimating LF prevalence and assessing whether elimination had been sustained. Finger-prick blood samples were tested for LF antigen and antibodies; antigen-positive samples were screened for microfilariae. One participant was antigen-positive (0.1%, 95% CI 0.02-0.88), and no microfilariae were detected, indicating sustained elimination. Ten participants were antibody-positive (five Wb123, four Bm14, one dual-positive). Semi-structured interviews provided operational insights, indicating that integrating LF-PVS into the WHO STEPwise NCD risk factor survey was resource-efficient, logistically feasible, and acceptable to both health workers and the community. This study is the first to examine the integration of NCD and communicable disease surveillance in the Pacific.

Indexed as

Communicable DiseasesElephantiasis, FilarialNoncommunicable DiseasesAdolescentAdultAnimalsAntibodies, HelminthAntigens, HelminthFemaleHumansMaleMicronesiaMiddle AgedPacific IslandsPopulation SurveillancePrevalenceAntibodies, HelminthAntigens, HelminthEpidemiologyNeglected diseasesPacific islandsPublic health surveillance

Identifiers

PMID42265337
PMCPMC13500854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.